These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 3238010

  • 1. PAF increases vascular permeability in selected tissues: effect of BN-52021 and L-655,240.
    Sirois MG, Jancar S, Braquet P, Plante GE, Sirois P.
    Prostaglandins; 1988 Nov; 36(5):631-44. PubMed ID: 3238010
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG, de Lima WT, de Brum Fernandes AJ, Johnson RJ, Plante GE, Sirois P.
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether.
    Sánchez-Crespo M, Fernández-Gallardo S, Nieto ML, Baranès J, Braquet P.
    Immunopharmacology; 1985 Oct; 10(2):69-75. PubMed ID: 3840779
    [Abstract] [Full Text] [Related]

  • 11. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
    Baranes J, Hellegouarch A, Le Hegarat M, Viossat I, Auguet M, Chabrier PE, Braquet P.
    Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
    [Abstract] [Full Text] [Related]

  • 12. Studies on the mechanism of PAF-induced vasopermeability in rat lungs.
    de Lima WT, Kwasniewski FH, Sirois P, Jancar S.
    Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):245-9. PubMed ID: 7784472
    [Abstract] [Full Text] [Related]

  • 13. Release of eicosanoids in rat peritoneal cavity stimulated with platelet-activating factor (PAF). Effect of the PAF-antagonist BN-52021.
    Jancar S, Braquet P, Sirois P.
    Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):23-4. PubMed ID: 2548218
    [Abstract] [Full Text] [Related]

  • 14. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor.
    Jancar S, De Giaccobi G, Mariano M, Mencia-Huerta JM, Sirois P, Braquet P.
    Prostaglandins; 1988 May; 35(5):757-70. PubMed ID: 2969600
    [Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor primes the effects of platelet-activating factor on rat vascular permeability.
    Sirois MG, Plante GE, Braquet P, Sirois P.
    J Lipid Mediat; 1990 May; 2 Suppl():S109-17. PubMed ID: 2133277
    [Abstract] [Full Text] [Related]

  • 16. Involvement of platelet-activating factor (PAF) in endotoxin-induced intestinal motor disturbances in rats.
    Pons L, Droy-Lefaix MT, Braquet P, Buéno L.
    Life Sci; 1989 May; 45(6):533-41. PubMed ID: 2570338
    [Abstract] [Full Text] [Related]

  • 17. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
    Etienne A, Hecquet F, Soulard C, Spinnewyn B, Clostre F, Braquet P.
    Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
    [Abstract] [Full Text] [Related]

  • 18. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F, Whittle BJ, Moncada S.
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [Abstract] [Full Text] [Related]

  • 19. Modulation by nitric oxide of platelet-activating factor-induced albumin extravasation in the conscious rat.
    Filep JG, Földes-Filep E.
    Br J Pharmacol; 1993 Dec; 110(4):1347-52. PubMed ID: 8306074
    [Abstract] [Full Text] [Related]

  • 20. Effect of long-term treatment with platelet-activating factor on IL-1 and IL-2 production by rat spleen cells.
    Pignol B, Hénane S, Sorlin B, Rola-Pleszczynski M, Mencia-Huerta JM, Braquet P.
    J Immunol; 1990 Aug 01; 145(3):980-4. PubMed ID: 2373865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.